Research suggests Pfizer-BioNTech COVID-19 vaccine reprograms innate immune responses
By
[Links nur für registrierte Nutzer]May 10 2021
Researchers in The Netherlands and Germany have warned that Pfizer-BioNTech’s coronavirus disease 2019 (COVID-19) vaccine induces complex reprogramming of innate immune responses that should be considered in the development and use of mRNA-based vaccines.
Jorge Domínguez-Andrés and colleagues say that while the vaccine has been shown to be up to 95% effective in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and subsequent COVID-19, little is known about the broad effects the vaccine may have on the innate and adaptive immune responses.
In the current study (
[Links nur für registrierte Nutzer]*
), the research team from Radboud University Medical Center and Erasmus MC in the Netherlands, and the Helmholtz-Centre for Infection Research (HZI), Hannover Medical School (MHH), and the University of Bonn, in Germany, confirmed
[Links nur für registrierte Nutzer] BNT162b2 vaccination at inducing effective humoral and cellular immunity against several SARS-CoV-2 variants.